Form 4: International Stem Cell CORP Director Don Wright Acquires Stock Options

Director Don Wright acquired stock options in International Stem Cell CORP on June 11, 2024.

Summary

• On June 11, 2024, Don Wright, a director of International Stem Cell CORP, acquired stock options.
• Wright acquired 30,000 stock options exercisable at $0.12, vesting on the earlier of June 11, 2025, or the date of the 2025 Annual Meeting of Stockholders.
• Wright also acquired 361,111 stock options exercisable at $0.12, vesting in four equal quarterly increments beginning September 11, 2024.
• Following these transactions, Wright directly owns 30,000 and 361,111 derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock option grants to a director. While option grants can be seen as a positive incentive, this filing itself doesn't provide strong positive or negative signals.

Positives

• The acquisition of stock options by a director could be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

This is a standard SEC Form 4 filing, reflecting a change in beneficial ownership by a company insider. Option grants are a common form of executive compensation in publicly traded companies.

Key Dates

Keywords

stock options, director, ISCO.OB, International Stem Cell CORP, Don Wright, acquisition, Form 4